About us
About the Company
Discovery laboratories, the company established in 2006 and is a global player in intermediates and API manufacturing having a strong research and manufacturing team supported by state of the art facility,.
We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry
The company has grown consistently to become one of the leading manufacturers of intermediates / Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. has multi product facility in operation
Discovery is a trusted manufacturer of Active Pharma Ingredients (API’s), Advanced Intermediates.
Discovery is an E.M.A (HPRA) and ISO 9001:2008 Certified Company and is currently having ever appreciating international and domestic customer base.
Meet Our executies:
Sekhara Rao M V
Chairman
Has distinguished experience as projects manager and entrepreneur. Worked for Birla group company and executed projects in the Middle east . Became an entrepreneur by setting up chemical equipment fabrication in India to supply to the emerging pharmaceutical industry in Hyderabad. Diversified into consumer plastics, building materials, Composites.
Prashanth Manne
CEO
Holds a chemical engineering degree from Cleveland State University, Ohio and Management Diploma from Indian School of Business, Hyderabad.
Nishita Nadella
CFO
She worked in IBM India for five years in the Finance Department prior to joining Discovery. She is a CA and CS.
Sivaram Mothukuri
Technical Team
Holds chemical engineering degree. Has more than 10 years experience in Quality and Operations. Worked for Dr. Reddys LAbs, Mylan Labs, Shilpa Medicare etc.
Our Mission
Setting benchmark as a leading quality manufacturer
Develop cost effective process for API's, manufacture and market them in regulatory markets
Forging relationships with top notch companies for contract manufacturing and contract research projects
Manufacture & supply intermediates to patent holders in US & EU
Broaden our product base across various therapeutic segments